Managing the four-prong threat of CDI, antibiotics, the flu season and COVID-19

A recently published paper, Managing the four-prong threat of CDI, antibiotics, the flu seasons, and COVID -19, discusses the impact of COVID-19 on C. difficile infection rates.  Due to the pandemic,  health care facilities have adopted numerous mitigation procedures against COVID – 19 which have also reduced influenza rates and helped to lower the rate of hospital-acquired infections such as CDI, even when the rate of antibiotic use has not decreased. It is important to remain vigilant for C. difficile infections as conditions continue to evolve.

August 16, 2021 News

TECHLAB®, Inc. develops, manufactures, and distributes rapid non-invasive intestinal diagnostics in the areas of intestinal inflammation, antibiotic associated diarrhea and parasitology.